Manufacturers’ 340B Final Rule Summit

2016 Speaking Faculty

Don Bell
Senior Vice President & General Counsel
National Association Chain Drug Stores

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

Alice Valder Curran
Partner
Hogan Lovell

Marcus Farbstein
Director, Public Policy and Government Markets
Medivation

Joseph P. Fuhr Jr., PhD
Professor Emeritus of EconomicsWidener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

Michael Hepburn
Senior Director, Government Contracts
Janssen

Richard Holsapple, RPh
Pharmacy Services Manager, Oregon MMIS
HP Enterprise Services

Gary L. Horne, RPh, MHSA
Director of Pharmacy
San Mateo Medical Center

Sarah Karlin-Smith
Healthcare Reporter
POLITICO & POLITICO PRO

Gavin Magaha, PharmD, MS
Manager, 340B Education and Compliance Support
APEXUS Formerly, Manager, Medication Control and Compliance
Wake Forest Baptist Health

Paula Martins
Director, Commercial Operations
Helsinn Therapeutics (U.S.), Inc.

Colleen Menges
Director, Government Contracts, Contract Strategy Management
Johnson & Johnson

Jill Page
Director, Pharma Government Pricing Strategies
Fresenius Medical Care

Kavita Patel, MD
Nonresident Senior Fellow
Brookings Institution

Stephen E. Ruscus
Partner
Morgan, Lewis & Bockius LLP

William A. Sarraille
Partner
Sidley

John Shakow
Partner
King & Spalding

Maureen Testoni
Senior Vice President and General Counsel
340B Health

Denise Thomas
Manager, Government Pricing
Gilead

Stephanie Trunk
Attorney
Arent Fox LLP

Darnell Turner
Director, Analysis, Rebates, and Government Pricing
Endo Pharmaceuticals

Charles Washington, CFE, CPP, CICA
Director, Global Compliance and Security
Pfizer

Constance Wilkinson, JD
Partner
EPSTEIN BECKER GREEN

Donna Lee Yesner
Senior Counsel, Morgan
Lewis & Bockius LLP